Back to Search
Start Over
HiFiBiO Therapeutics Announces a Global Strategic Partnership With ABL Bio for the Co-Development of a SARS-CoV-2 Neutralizing Antibody
- Source :
- Plus Company Updates. September 15, 2020
- Publication Year :
- 2020
-
Abstract
- CAMBRIDGE: HiFiBiO Therapeutics has issued the following press release: HiFiBiO Therapeutics, a clinical-stage multinational biotherapeutics company focused on the development of novel antibodies in immunomodulation, today announced a partnership agreement [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.635493373